|
GB937214A
(en)
|
1961-06-02 |
1963-09-18 |
J F Macfarlan & Company Ltd |
Oripavine derivatives
|
|
GB925723A
(en)
|
1960-09-05 |
1963-05-08 |
J F Macfarlan & Company Ltd |
Novel thebaine derivatives
|
|
JPS59184182A
(ja)
|
1983-04-02 |
1984-10-19 |
Res Inst For Prod Dev |
３−ベンゾイルチオ−４、５α−エポキシ−７α−〔１（Ｒ）−ヒドロキシ−１−メチルベンチル〕−６−メトキシ−１７−メチル−６、１４−エンド−エタノモルヒナン
|
|
JPS62153214A
(ja)
|
1985-12-26 |
1987-07-08 |
Nitto Electric Ind Co Ltd |
医薬製剤
|
|
JPS62281815A
(ja)
|
1986-05-27 |
1987-12-07 |
Teisan Seiyaku Kk |
貼付剤及びその製造法
|
|
JPS63201119A
(ja)
|
1987-02-17 |
1988-08-19 |
Kao Corp |
貼付剤組成物
|
|
US4891377A
(en)
|
1988-12-02 |
1990-01-02 |
Board Of Regents Acting For And On Behalf Of University Of Michigan |
Transdermal delivery of the narcotic analgesics etorphine and analogs
|
|
PT95069B
(pt)
|
1989-08-24 |
1997-10-31 |
Searle & Co |
Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
|
|
US5271940A
(en)
|
1989-09-14 |
1993-12-21 |
Cygnus Therapeutic Systems |
Transdermal delivery device having delayed onset
|
|
US5633259A
(en)
|
1992-09-21 |
1997-05-27 |
United Biomedical, Inc. |
Method for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addiction
|
|
WO1994006426A1
(en)
|
1992-09-21 |
1994-03-31 |
Qin Bo Yi |
Methods for identifying and using low/non-addictive opioid analgesics
|
|
JP2819236B2
(ja)
|
1994-05-06 |
1998-10-30 |
日東電工株式会社 |
経皮吸収製剤
|
|
CZ292151B6
(cs)
|
1995-06-07 |
2003-08-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Transdermální náplast pro podávání 17-deacetylnorgestimátu samotného nebo v kombinaci s estrogenem
|
|
AUPN603895A0
(en)
|
1995-10-19 |
1995-11-09 |
University Of Queensland, The |
Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
|
|
US6103258A
(en)
|
1996-04-12 |
2000-08-15 |
Simon; David Lew |
Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6-Methylenemorphinan-3,14 diol molecule for optimizing dopamine homeostasis during administration of opioid analgesics
|
|
KR100204659B1
(ko)
|
1996-05-28 |
1999-06-15 |
강재헌 |
신규한 부프레노핀계 진통제용 화합물
|
|
JPH10231248A
(ja)
|
1997-02-19 |
1998-09-02 |
T T S Gijutsu Kenkyusho:Kk |
ジヒドロエトルフィン含有経皮吸収型製剤
|
|
DE69942928D1
(de)
|
1998-08-27 |
2010-12-23 |
Pfizer Health Ab |
Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung
|
|
US6194382B1
(en)
|
1999-03-03 |
2001-02-27 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists
|
|
US6765010B2
(en)
|
1999-05-06 |
2004-07-20 |
Pain Therapeutics, Inc. |
Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
|
|
US6312716B1
(en)
|
1999-05-10 |
2001-11-06 |
Peierce Management Llc |
Patch and method for transdermal delivery of bupropion base
|
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
|
JP4659943B2
(ja)
|
2000-02-25 |
2011-03-30 |
帝三製薬株式会社 |
塩酸ブプレノルフィン含有貼付剤
|
|
DE60143477D1
(de)
|
2000-04-26 |
2010-12-30 |
Watson Pharmaceuticals Inc |
Verminderung der nebenwirkungen bei der oxybutynin-therapie
|
|
US6372252B1
(en)
|
2000-04-28 |
2002-04-16 |
Adams Laboratories, Inc. |
Guaifenesin sustained release formulation and tablets
|
|
MXPA02003670A
(es)
|
2000-07-13 |
2003-01-28 |
Euro Celtique Sa |
Sales y bases de 17-(ciclopropilmetil)-4,5 alfa-epoxi-6-metilenomorfinan-3,14 diol para optimizar la homeostasis de dopamina durante la administracion de analgesicos.
|
|
US7141250B2
(en)
|
2001-08-06 |
2006-11-28 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing bittering agent
|
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
AU2002322169B2
(en)
|
2001-08-10 |
2008-10-30 |
Monash University |
Derivatives of morphine-like opioid compounds
|
|
CN1233645C
(zh)
|
2001-09-14 |
2005-12-28 |
中国人民解放军军事医学科学院毒物药物研究所 |
新的东罂粟碱衍生物及其医药用途
|
|
US20040024005A1
(en)
|
2002-01-23 |
2004-02-05 |
The Regents Of The University Of California |
Methods and compositions for reducing the development of drug tolerance and/or physical dependence
|
|
US20060177381A1
(en)
|
2002-02-15 |
2006-08-10 |
Howard Brooks-Korn |
Opiopathies
|
|
US20040033253A1
(en)
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
|
US20030191147A1
(en)
|
2002-04-09 |
2003-10-09 |
Barry Sherman |
Opioid antagonist compositions and dosage forms
|
|
CA2487123C
(en)
|
2002-05-28 |
2011-10-18 |
Labtec Gesellschaft Fuer Technologische Forschung Und Entwicklung Mbh |
Patch containing fentanyl
|
|
AU2003251482A1
(en)
|
2002-06-10 |
2003-12-22 |
Euro-Celtique, S.A. |
Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
|
|
AU2003268144A1
(en)
|
2002-08-20 |
2004-03-11 |
Euro-Celtique, S.A. |
Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
|
|
AU2002951965A0
(en)
|
2002-10-09 |
2002-10-24 |
Monash University |
Amidine compounds
|
|
TWI296531B
(en)
|
2002-10-18 |
2008-05-11 |
Hisamitsu Pharmaceutical Co |
Transdermal adhesive preparations for topical administration of fentanyl
|
|
TW200500067A
(en)
|
2003-01-21 |
2005-01-01 |
Control Delivery Sys Inc |
Salts of codrugs and uses related thereto
|
|
US20040208917A1
(en)
|
2003-04-16 |
2004-10-21 |
Wilfried Fischer |
Transdermal systems for the release of clonidine
|
|
MXPA05011703A
(es)
|
2003-04-30 |
2006-01-23 |
Purdue Pharma Lp |
Forma de dosis transdermica resistente a los retardadores que comprende un componente de agente activo y un componente de agente adverso en el sitio distal de la capa del agente activo.
|
|
US20050113365A1
(en)
|
2003-11-10 |
2005-05-26 |
Sir Isaac Newton Enterprises Llc |
Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome
|
|
CN100500151C
(zh)
|
2004-04-02 |
2009-06-17 |
北京万全阳光医药科技有限公司 |
一种水溶性药物舌下给药制剂
|
|
JP2007538091A
(ja)
|
2004-05-17 |
2007-12-27 |
ファーマコフォア・インコーポレイテッド |
痛みを処置または予防するための組成物および方法
|
|
EP1868593A2
(en)
|
2005-04-07 |
2007-12-26 |
Hythiam, Inc. |
Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
|
|
US8574604B2
(en)
|
2005-04-15 |
2013-11-05 |
Interface Biologics, Inc. |
Methods and compositions for the delivery of biologically active agents
|
|
KR100764679B1
(ko)
|
2005-07-22 |
2007-10-09 |
익수제약 주식회사 |
파록세틴을 함유하는 경피투여용 패취제
|
|
EP1928881A2
(en)
|
2005-08-19 |
2008-06-11 |
Pharmacofore, Inc. |
Prodrugs of active agents
|
|
WO2007052308A2
(en)
|
2005-11-03 |
2007-05-10 |
Brain N' Beyond Biotech Pvt. Ltd. |
Glyco-phosphorylated biologically active agents
|
|
GB0523031D0
(en)
|
2005-11-11 |
2005-12-21 |
Yaupon Therapeutics |
Enhancement of morphine analgesia by s(-)-norketamine
|
|
TWI389709B
(zh)
|
2005-12-01 |
2013-03-21 |
Novartis Ag |
經皮治療系統
|
|
US8071125B2
(en)
|
2005-12-09 |
2011-12-06 |
Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. |
Transdermal patch containing isosorbide dinitrate and bisoprolol
|
|
CA2680690A1
(en)
|
2006-03-15 |
2007-09-20 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
|
|
USD576282S1
(en)
|
2006-06-16 |
2008-09-02 |
Activatek, Inc. |
Adhesive transdermal medicament patch
|
|
USD625017S1
(en)
|
2006-08-11 |
2010-10-05 |
Hisamitsu Pharmaceutical Co., Inc. |
Medical transdermal patch
|
|
DE102006050558B4
(de)
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
|
CN100512817C
(zh)
|
2006-11-15 |
2009-07-15 |
闫章年 |
复方噻拉嗪注射液及制备工艺
|
|
DE102006054731B4
(de)
|
2006-11-21 |
2013-02-28 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
|
|
JP2010514789A
(ja)
|
2006-12-27 |
2010-05-06 |
アベール ファーマシューティカルズ インコーポレイテッド |
副腎皮質ステロイド投与のための経皮的方法及びパッチ
|
|
CN101781303A
(zh)
|
2007-03-06 |
2010-07-21 |
马林克罗特公司 |
季n-烷基吗啡喃生物碱盐的制备方法
|
|
CN101147739B
(zh)
|
2007-07-06 |
2010-12-08 |
北京康倍得医药技术开发有限公司 |
含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
|
|
KR100929560B1
(ko)
|
2008-01-09 |
2009-12-03 |
에코 퍼시픽 엘티디 |
그라니세트론을 함유한 매트릭스 형태의 경피 흡수제
|
|
WO2009139411A1
(ja)
|
2008-05-15 |
2009-11-19 |
久光製薬株式会社 |
パロノセトロンを含有する経皮吸収製剤
|
|
TWI541246B
(zh)
|
2008-12-08 |
2016-07-11 |
歐陸斯迪公司 |
二氫羥戊甲嗎啡
|
|
EP2298277A1
(en)
|
2009-09-09 |
2011-03-23 |
Labtec GmbH |
Transdermal patch formulation
|
|
DE102010040299A1
(de)
|
2010-09-06 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
|